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Abstract: Different challenges are presented by the
variety of malaria transmission environments present in
the world today. In each setting, improved control for
reduction of morbidity is a necessary first step towards
the long-range goal of malaria eradication and a priority
for regions where the disease burden is high. For many
geographic areas where transmission rates are low to
moderate, sustained and well-managed application of
currently available tools may be sufficient to achieve local
elimination. The research needs for these areas will be to
sustain and perhaps improve the effectiveness of
currently available tools. For other low-to-moderate
transmission regions, notably areas where the vectors
exhibit behaviours such as outdoor feeding and resting
that are not well targeted by current strategies, new
interventions that target predictable features of the
biology/ecologies of the local vectors will be required.
To achieve elimination in areas where high levels of
transmission are sustained by very efficient vector species,
radically new interventions that significantly reduce the
vectorial capacity of wild populations will be needed.
Ideally, such interventions should be implemented with a
one-time application with a long-lasting impact, such as
genetic modification of the vectorial capacity of the wild
vector population.
Introduction
The overarching goal of malaria vector control is to reduce the
vectorial capacity of local vector populations below the critical
threshold needed to achieve a malaria reproduction rate (R0, the
expected number of human cases that arise from each human case
in a population) of less than 1. Because of the long extrinsic
incubation time of Plasmodium in its Anopheles vectors, the most
effective vector control strategies in use today rely on insecticide
interventions like indoor residual insecticide sprays (IRSs) and
long-lasting insecticide-treated nets (LLINs) that reduce vector
daily survival rates [1]. For many malaria-endemic regions, these
tools can make substantial contributions to malaria control and
may be sufficient for local malaria elimination. These were the
only regions considered by the recent Malaria Elimination Group
(MEG). Regions where existing interventions will not be
sufficiently effective include those where high rates of transmission
occur. For example, in much of sub-Saharan Africa, where the
entomological inoculation rates (EIRs) can reach levels approach-
ing 1,000 infective bites per person per year [2,3], the best use of
existing interventions can only help to reduce annual inoculation
rates by approximately an order of magnitude. Additional
interventions will clearly be required, however, both for regions
with extremely high rates of transmission and for regions where
the major vectors are not susceptible to current control tools [4].
To develop vector-targeted interventions in support of malaria
eradication in all disease endemic settings that are unfettered by
these limitations, three challenges need to be recognized and
addressed with great urgency today. The first challenge, for which
near-term product development is essential, is the preservation
and improvement of the utility of existing insecticide-based
interventions. This challenge will require a vibrant research
agenda that develops a broader range of insecticides with novel
modes of action that can circumvent emerging resistance to
existing insecticides, particularly the pyrethroids. This agenda
must include the creation of strategies for the use of new
insecticides that minimize the emergence of resistance. A related
and critical focus of the agenda will be the development of rapid
and affordable methods for detecting the emergence of epidemi-
ologically important levels of insecticide resistance. Because of the
fundamental dependence of many current malaria control and
elimination programs on pyrethroid insecticide–based LLINs and
the emerging problem of pyrethroid insecticide resistance in many
vector species, especially in sub-Saharan Africa, development of
new insecticides that can be used in LLINs is the most immediate
need [5].
The second challenge is development of interventions that affect
vector species not effectively targeted by current tools. At least
three dozen different species of Anopheles mosquitoes are important
in malaria transmission worldwide. Many of these species are not
susceptible to tools like IRS and LLINs, which target indoor
feeding and/or resting vectors [6]. Control of malaria transmitted
by these vectors will require new interventions that target other
aspects of their biology, including outdoor feeding and resting,
oviposition site preference, mating behaviour, or sugar meal
selection. Major features of the agenda to tackle this challenge will
be defining the vector species for which such new tools are most
important and devising tools that will be effective for multiple
important vector species.
Review articles synthesize in narrative form the best available evidence on a topic.
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The most difficult research challenge for vector control during
all phases of malaria elimination/eradication but particularly
during the final stages of eradication is development of novel
approaches that will permanently reduce the very high vectorial
capacities of the dominant malaria vectors in sub-Saharan Africa.
Without such approaches, local elimination in Africa will be
extremely challenging. Even when elimination is achieved, the
residual vectorial capacities of local mosquitoes will pose a
lingering threat of massive epidemics should malaria be reintro-
duced to a population that has lost partial immunity. Measures to
reduce vectorial capacities will need to be either extremely cost-
effective, if they are to be sustained until eradication is achieved, or
able to effectively yield a long-term, sustained reduction of
transmission following a one-time application. Genetic control
programs (which could be achieved by a variety of genetic
manipulation approaches) designed to permanently reduce the
vectorial capacities of natural vector populations have received the
most attention to date, and currently represent some of the most
promising ideas in this area [7], but the development of other,
novel approaches must be strongly encouraged.
It is these three challenges that the malERA Consultative Group
on Vector Control concentrated on during its deliberations, the
results of which are presented here.
Current Tools and Resource Gaps
The key goal of the malERA Consultative Group on Vector
Control was to help define the research and development agenda that
will be required to sustain and improve the effectiveness of currently
available tools like LLINs and IRS and to develop new vector-
targeted tools that can be used to interrupt transmission in
environments or at intensities that these existing tools cannot reach.
It is clear that new technology will be required in very high
transmission areas to reduce vectorial capacity and achieve even
effective control, let alone elimination. The main aim of this paper is
to define a research and development agenda that focuses on those
new research questions and knowledge gaps that arise specifically in
response to the call for malaria eradication, and that would not
otherwise be at the top of the agenda (Table 1). It is particularly
important to recognize that this operationally specified goal
significantly limits the scope of research and development under
consideration, and this document should not be the basis for all vector
research related to malaria. Our article does, however, describe the
challenges for vector control methodology in the elimination phase,
for detecting and monitoring areas of persistent transmission, and for
detecting and monitoring nonrandom transmission leading to
outbreaks. We also discuss the requirements for rapid and urgent
intervention when outbreaks occur (see also [8]).
The Consultative Group identified four key components to
successful vector control within an eradication agenda. First, the
ecology of vectors responsible for malaria transmission in those
regions of the world where current tools are insufficient for
elimination needs to be understood. Second, sets of synergistic or
complementary interventions tools need to be developed and
applied through rationally designed programs that can be spatially
and temporally combined into effective intervention programs.
Third, appropriate monitoring and evaluation tools that can guide
the application and evolution of control and elimination programs
as malaria endemicity is pushed towards local elimination need to
be developed and applied. Finally, there is a critical need for built-in
flexibility in programs so that where initial efforts fail, they can
adapt to circumstances by incorporating and implementing new
approaches. Thus, as malaria programs are scaled up, vector
control will have a major role in disease burden reduction but, as
programs become increasingly successful in reducing transmission,
accurate estimation of the point at which large-scale vector control
activities can be relaxed will become critical. Premature removal of
mainstream vector control, either through planned reductions in
activities or through failure of long-lasting interventions like LLINs
or IRS as resistance evolves, is likely in many instances to lead to a
Summary Points
N Improved vector control is essential for the elimination/
eradication of malaria
N In regions where transmission rates are low or moderate,
existing tools may be sufficient to achieve elimination
but in many malaria-endemic regions, new vector
control interventions, including new insecticides and
formulations, are needed
N Better understanding of vector biology is an essential
prerequisite for the development of new control
interventions
N Sustained commitment to the development of radically
new approaches such as the genetic modification of
mosquitoes is critical to reduce the high vectorial
capacity in some malaria-endemic regions
N Innovative cross-disciplinary technologies are needed to
control outdoor biting and resting mosquito vectors, to
measure transmission, and to educate communities
about vector control
Table 1. Vector control interventions required for sustained control and for eradication.
Sustained Control Eradication
Better vector monitoring and evaluation information to target interventions
Effective insecticides for LLINs and/or IRS Effective insecticides for LLINs and/or IRS
Resistance monitoring and management Resistance monitoring and management
Vector identification and incrimination Vector identification and incrimination
Appropriate integrated vector management Appropriate integrated vector management
Targeted interventions for outdoor biting and resting mosquitoes
Novel approaches to reduce permanently the high vectorial capacity
of major vectors (e.g., genetic modification)
Effective consumer products for vector control
doi:10.1371/journal.pmed.1000401.t001
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catastrophic increase in morbidity and mortality because of
resurgent malaria in a nonimmune population [8,9].
The exact role of vector control as countries enter the elimination
phase of activities will be situation specific. However, valuable
lessons can be drawn from the WHO Global Malaria Eradication
Program (GMEP) of the 1950s and 1960s [10], in which vector
control alone was considered to be enough in many situations to
eliminate malaria. Although this approach was successful in some
cases, success was often short-lived [11,12]. Another valuable lesson
can be learned from current efforts to eradicate filariasis. For this
vector-borne disease, multiple rounds of mass drug administration
in many countries divorced from targeted vector control have not
achieved the predicted interruption in transmission [13].
Indeed, there is now a consensus that malaria elimination with
current tools is far more likely if the best available tools are used in
combinations. In the past two decades, especially in an African
context, the combination of drugs and vector control with
impregnated nets has been highlighted for its role in the reduction
of morbidity and mortality [14]. However as malERA sets out a
research and development agenda for elimination/eradication and
vector control, other interventions must be considered primarily in
terms of their impact on malaria infection and transmission, not
instead of, but in addition to, their role in prevention and
modification of disease.
We highlight the research and development areas identified as
priority areas by the Consultative Group before providing a
summary research and development agenda that draws together
the various strands of our discussions.
The Development of a Formal Analytical
Framework
The malaria eradication agenda would clearly be advanced by
the development of a formalized analytical framework that
facilitates the collection, analysis, and central presentation of
relevant information (Figure 1). Such a framework could signifi-
cantly help elimination/eradication programs optimize the use of
current vector control tools. In addition, when available tools are
properly deployed and transmission persists, such a framework
could also highlight the knowledge gaps that currently limit
accurate development of clear target product profiles (TPPs) for
new tools. The generation and sharing of information from
systematic assessments of the results of malaria elimination
programs across different epidemiological settings will help drive
the development of new technologies that will be needed to
achieve elimination in more intransigent transmission settings.
The most immediate task of the analytical framework will be to
focus research and development resources on the malaria
transmission settings for which new or improved elimination tool
development is most critical. These settings include much of sub-
Saharan Africa and parts of Papua New Guinea, regions where
vector populations are capable of sustaining transmission at high
vectorial capacities that significantly exceed the possibility of
elimination with current tools. In addition, however, there may be
other malaria transmission regions of more modest vectorial
capacity where important current tools such as IRS and LLINs
have little impact because the important vectors do not enter
houses to rest or to seek blood meals. Some information already
exists that can be brought together to define these high-risk regions
[15–17]. For other regions, however, problems may become
obvious only when the application of current interventions proves
insufficient.
The analytical framework should systematically coordinate
available data from disparate multidisciplinary resources, includ-
ing both peer-reviewed and ‘‘grey’’ literature, via a Web portal to
facilitate access and analysis. The Consultative Group’s recom-
mendation is that disparate multidisciplinary resources are
Figure 1. A formalized analytical framework for the collection, analysis, and central presentation of relevant information. M&E,
monitoring and evaluation. Image credit: Fusio´n Creativa.
doi:10.1371/journal.pmed.1000401.g001
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brought together in a coherent format that will allow the objective
assessment of the knowledge base as it relates to the performance
of current tools. The ideal format would allow the systematic
assessment of issues arising in countries that have already
eliminated malaria and in countries that are still in the first wave
of malaria elimination, in isolation and in combination, and would
allow comparisons to be made of tool performance in different
epidemiological settings. Some of this information—for example,
the worldwide distribution of malaria risk and information on the
worldwide distribution of important malaria vectors—already
exists in centralized resources and needs only be made more
readily available. However, other kinds of important information
will need to be assembled from disparate sources (for example,
field data from major malaria research and control programs and
the very significant but inaccessible literature that emerged from
the first GMEP) or generated de novo (for example, the
determination of the specific malaria transmission behaviours of
vectors that have only recently been determined to be members of
cryptic species complexes [18]).
As the elimination agenda progresses, this growing body of
information can be used to develop and use models of vector
biology and transmission and to test intervention hypotheses such
as the effect of combining available control tools into integrated
control programs. Further, modeling can be used to identify
opportunities to develop new interventions and establish the
settings where vector control–targeted interventions are inappro-
priate. It will be particularly important to invest in new
interventions that are likely to impact additively or even
synergistically with existing tools. Modeling can be an important
first step in evaluating such potential interactions (also see [9]).
The Preservation and Improvement of Current
Tools
The obvious major threat to current vector-targeted interven-
tions is insecticide resistance, and addressing this problem will be
both an important near-term research concern and a continuing,
long-term concern as new insecticide formulations and ingredients
are developed and used. Furthermore, this problem is critical for
control efforts as well as for elimination and eradication efforts.
Pyrethroids are the only insecticides currently used operationally
on LLINs and are also the dominant insecticide class in IRS, but
resistance to this insecticide class is now widespread, with multiple
resistance mechanisms spreading in the two major African malaria
vectors [19,20]. Although the operational impact of these
resistance indicators remains to be established, multiple studies
have demonstrated the direct association of resistance measures
with entomological indicators such as mosquito mortality, biting
rates, and blood feeding success.
Sporadic insecticide resistance monitoring is undertaken by
control programs, predominantly using WHO bioassays, but the
results from these bioassays are rarely linked to any assessment of
control failure. Moreover, resistance-monitoring efforts are not
typically used to provide formal guidance to control programs on
the selection of alternative vector control strategies in the presence
of resistance. Because of the very large number of vector species,
the many insecticides in use, and the large numbers of potential
resistance mechanisms, choosing the correct vector control
strategy is clearly a complex and daunting problem. An essential
first step towards developing a rational solution will be to develop
and provide new tools for the quantitative monitoring of different
forms of resistance in different vector species. Monitoring could be
done through the provision of public protocols, through training
and the provision of kits, or by establishing a regional service. The
potential complexity of meaningful data generation and interpre-
tation suggests that the last option may be preferable. Indeed, we
note that this type of activity could readily be combined in a
monitoring and evaluation framework with a laboratory service
that provides drug resistance or serology monitoring capability. In
addition, data on the temporal and geographic distribution of
insecticide resistance need to be efficiently assembled and made
publicly available through a formal analytic framework to help
guide both control program and research decisions.
LLINs, IRS, and larvicides attack different behaviours or life
stages of the mosquito. There is some evidence that LLINs and IRS
used in combination may be synergistic, although both target adult
female mosquitoes indoors [21]. Within an eradication agenda, the
cost-effectiveness and benefits of such combinations need to be
assessed. The recommendation of the Consultative Group,
therefore, is that potential combinations of present and new control
tools be explored theoretically in a modeling framework [9], and
that potentially optimal integrated vector management strategies be
tested in large-scale field trials in different epidemiological settings to
assess their ability to reduce transmission and the burden of disease.
If insecticide resistance dramatically reduces our ability to reduce
transmission, it becomes a major threat to eradication, and
mitigating strategies must be tested in the field to contain resistance
in the absence of new alternative insecticides. Finally, insecticide-
resistance management technologies need to be developed for the
future that use combinations of vector control tools that do not
depend on the main classes of insecticide in current use. Such
combinations might include repellents, larvicides, environmental
management, and possibly pathogens.
Improvement of the Knowledge Base of Vector
Ecology
Malaria is transmitted in diverse epidemiological situations by a
wide range of potential combinations of ‘‘primary’’ and ‘‘second-
ary’’ vectors. Moreover, most widely recognized vector species are
members of cryptic species complexes [18] and even within
currently recognized complexes, further heterogeneities may exist
in vector population structure that can limit the effectiveness of
control tools [22]. The present vector control tools (LLINs and
IRS) were developed to reduce transmission in areas where the
primary vectors feed and/or rest indoors. When these interven-
tions are implemented under optimal programmatic conditions,
diligent monitoring will identify areas where there are limitations
in their effectiveness.
Failure to achieve the expected level of control may result from
a number of factors. Complex mixtures of vector species may be
present, including vectors with outdoor biting and resting
behaviours, or a more complex genetic structure within recognized
vector taxa. Moreover, vector populations can develop behav-
ioural as well as physiological forms of resistance to insecticides.
To assess the possible impact of behavioural evolution on the
effectiveness of vector control tools, and to better target vector
species or populations escaping these tools, we have to understand
both larval and adult ecologies and behaviours. At the present, we
have only a limited understanding of the ecology and population
structure of some of the major vectors, such as An. gambiae in
Africa. Unfortunately, even less is known about where many of the
other important vectors feed, rest, mate, and oviposit, or about
their population structure, or even the extent of their geographic
distributions. These deficiencies are due to both the lack of
adequate sampling and monitoring methods and a historical lack
of emphasis on the study of population biology of malaria vectors
in many parts of the world.
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Development of TPPs for new interventions that could
supplement existing control tools will require knowledge of the
critical points in the biology of different vector species. These
points should be features of a vector’s biology that are sufficiently
predictable to constitute a target for the control tool, such as a
predictable resting, blood- or sugar-feeding, oviposition, or mating
site. Technologies (see later) that enable accurate tracking of
mosquito movement in space and time are needed to establish
these critical points in the biology of different vector species.
The Development of New Vector-Targeted
Interventions
Near-Term Translation of Appropriate Interventions
Malaria vector control activities today are heavily reliant on the
distribution of LLINs or IRS. In some instances, these are
augmented with larval control or fortuitously complemented by
social housing schemes or economic development that negatively
impact on Anopheles mosquito breeding. This limited armamentar-
ium is, in part, the legacy of a malaria control approach developed
before and during the GMEP of the 1950s and 1960s that was
followed by a shift in the 1970s through the 1990s away from the
interruption of transmission to the control of morbidity and
mortality based largely on chemotherapy [11,12]. Research on
the control of malaria transmission was consequently very limited
and poorly coordinated both during the time of the GMEP, which
was characterized by overoptimistic expectations of the effectiveness
of DDT, and in the years that followed when transmission was no
longer the main concern. Nonetheless, a number of proposed
alternative vector control methods have emerged recently, most of
which have not yet been extensively evaluated and developed (see
Table 2 for some examples). What is badly needed is a well-defined
development pipeline to ensure that the more promising among
these alternative methods are brought into mainstream operation
and that the less appropriate are down-selected.
For example, the development of cost-effective longer lasting
IRS formulations of different insecticide classes would remove the
economic and logistical arguments that preclude the use of IRS in
some settings. Today’s heavy reliance on pyrethroids for both
LLINs and IRS is driven both by a lack of new insecticides and by
limited development in formulation technology. The latter
problem is amenable to short-term resolution. Similarly, models
suggest that interventions that act on older adult mosquitoes are
less prone to resistance selection than traditional insecticides
[23,24], but this has still to be demonstrated operationally. Other
insecticides have failed to cross the translational gap because the
short residual shelf life of the formulations under operational
conditions is a major barrier to their commercialization. Until this
element of the critical pathway to commercial uptake is resolved,
many promising insecticides are unlikely to play an active role in
operational control.
Novel tools need proper evaluation in field trials and, if their
efficacy is demonstrated, they need testing in combination for their
effect on infection and transmission. We recommend that in
reviewing current and potential interventions within the analytical
framework, a commercial-style analysis of the development status
of the different interventions be undertaken (Figure 2) and the
barriers on the critical pathway to implementation be identified.
Once identified, the resources required to overcome these barriers
can be established and an appropriate risk benefit analysis can be
undertaken. This analysis will allow rapid movement away from
long lists of potential vector control interventions and towards a
better-defined list of actual interventions that can be coupled to
clear guidance on appropriate deployment in the different stages of
malaria elimination across a range of epidemiological settings.
Analysis of the development status should also include modeling to
guide selection and testing of combinations and settings where
they should be introduced (see also [9]).
New vector control tools will be needed in the short and
medium term as the current tools will be inadequate for malaria
elimination in most settings. The strategy outlined above will allow
researchers and developers to capitalize on information that is
already in the public domain and to efficiently and cost-effectively
develop the most appropriate new tools in the short term that
Table 2. Examples of novel tool development and intended objectives.
Sustained-Use Interventions Time-Limited Interventions
Category Objective Category Objective
Insecticides and related chemical agents
(synthetic and natural [‘‘bio-prospecting’’])
for environmental, dwelling, and systemic
applications (humans or animals)
Control, elimination Biological or chemical agents that
affect age structure (decrease extrinsic
incubation period, for example,
Wolbachia spp.)
Control, elimination,
eradication
House design to impede vector access
and sustainability
Control, elimination Genetic approaches to reduce adult
longevity (‘‘death-on infection’’ genes
killing only those mosquitoes that
become infected)
Control, elimination,
eradication
Biological agents (plant, fungi, algae, predators,
niche competitors, insect viruses, and other
pathogens) for population suppression
Control, elimination Biological agents targeting pathogens,
for example, symbiotic organisms
engineered to kill pathogens
(paratransgenesis)
Control, elimination,
eradication
Ecological/environmental modification
(source reduction) targeting sites for breeding
(oviposition), subadult development, and
adult resting sites
Control, elimination Genetic approaches targeting
vector competence
Control, elimination,
eradication
Chemical attractants/repellent agents
(synthetic and natural [‘‘bio-prospecting’’])
for dwelling and personal applications that
would target both indoor and outdoor biting
Control, elimination
doi:10.1371/journal.pmed.1000401.t002
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could be useful additions to the armamentarium for malaria
eradication.
Longer-Term Development of Novel Sustained-Use
Interventions
To achieve malaria eradication, we will need to reduce regional
R0 to less than 1 and sustain transmission rates below this critical
threshold until global eradication can be achieved. Achieving this
goal will require both augmentation of current control methods and
the development of novel interventions to interrupt transmission in
ways that address a broad range of potential impediments, including
political instability, geographic isolation, and the development of
chemical or behavioural resistance. Perhaps the biggest difficulties
will be the economic and social challenges that will be associated
with the need to sustain the impact of such interventions in some
regions for very long periods, possibly decades, until the risk of
parasite reintroduction is no longer a concern.
Insecticide-based interventions for sustained use should not be
compromised by resistance. Models of resistance management
developed using data from control of agricultural insect pests and
from other large-scale vector control efforts indicate that stable,
long-term resistance management strategies require a minimum of
three active ingredients. These ingredients need different modes of
action, distinct metabolic detoxification pathways, and no
resistance to any of them should be present at the onset of the
program. The levels of resistance currently circulating in many
mosquito vectors to all registered public health pesticides precludes
such a system being established today [25]. Hence, it is vital that
we continue to develop new active ingredients to replace existing
insecticides when vectors develop significant resistance. The ideal
goal would be to do this in a time frame that allows multiple new
insecticides to be introduced together.
It is also important that a broader set of tools for targeting adult
female vectors be developed so that adult vector survival rates and
the resulting population age structure can be reduced to levels
where insufficient older female mosquitoes capable of supporting
parasite sporogonic development are present in the vector
population. The most critical needs will be for vector control
tools that complement existing methods by targeting aspects of the
mosquito’s life cycle that are not currently reached. New tools
could potentially be developed to target outdoor blood-meal or
sugar-meal feeding, for example, or to target mate-seeking or
ovipositing females. Understanding the biology of these behaviours
in the life cycle of important vectors could be the source of
powerful new interventions. Even control approaches that achieve
only a reduction in vector population density, such as interventions
targeted at larvae, could prove valuable if they are sufficiently cost-
effective and are complementary to existing tools.
Push-pull (repellent-attractant) technologies are well developed
for some insect pests in the agricultural arena, but this technology
has yet to be brought to bear on malaria control [26]. Our rapidly
developing understanding of the mosquito sensory system, coupled
to development of high-throughput screening technologies, should
allow us to develop more effective attractants and repellents for
mosquitoes within the next decade [27]. Modeling and experi-
mental analysis of the impact of these compounds should allow us
to develop new, targeted strategies for control. This technology
also lends itself well to the extensive consumer market, which will
undoubtedly play a major role in sustaining elimination efforts by
reducing mosquito biting as mainstream vector control activities
are reduced. Indeed, this is a situation that already exists in
countries such as Sri Lanka and Mexico where the consumer
market for products that reduce biting nuisance is high and
national malaria control program vector control activities are
minimal.
Longer-Term Development of Novel Time-Limited
Interventions
The past decade has seen phenomenal advances in Anopheles
genomics and proteomics [28]. These advances, coupled with the
visionary but technically challenging development of mosquito
transgenics and other genetic manipulation techniques, open up
Figure 2. A scheme for the analysis of the development status of the different interventions; similar schemes are used in the
commercial development of drugs, for example. Image credit: Fusio´n Creativa.
doi:10.1371/journal.pmed.1000401.g002
PLoS Medicine | www.plosmedicine.org 6 January 2011 | Volume 8 | Issue 1 | e1000401
the possibility of developing novel technologies to suppress
mosquito populations or to make parasite-refractory mosquitoes,
and make mosquito-based transmission-blocking technologies
possible (Table 2). Such innovative new technologies may be key
tools in the eradication agenda in the highly malaria-endemic
regions of the world, in particular, much of sub-Saharan Africa,
because they can circumvent the extreme problems in control
program application that will be posed by intractable logistical,
technical, or political issues in many of these regions. Importantly
in intractable settings—for example, dense forests or politically
unstable areas—where the elimination of malaria may prove most
difficult, these technologies have the advantage that the mosquito
population itself acts as the distribution agent.
Fortunately, the number of different vector species for which such
technologies will need to be considered is limited, probably to only a
handful of species. Moreover, the highly technical research needed
to develop such tools for one major vector species will likely be fairly
easy to adapt or even transfer directly to others. We now need to
progress to the exacting but exciting translational phase of this
activity, which will involve selection of the most appropriate
technically robust technologies for operational implementation.
Development, analysis, and refinement of scale-up technology to
move progressively from the laboratory, to cage trials, and
ultimately to operational scale release of genetically modified
mosquitoes, and the establishment of the regulatory pathways for
commercialization and release are all needed. Finally and critically,
stakeholders, particularly in disease endemic countries, must be
persuaded to support the release of genetically modified mosquitoes.
Enabling Technologies
In order to establish TPPs for novel vector control products,
particularly for products that target outdoor feeding or resting
mosquitoes, we need to establish the critical points in the life cycle
of these mosquitoes where they congregate in numbers, are
susceptible to attraction by external stimuli, or come into contact
with their human hosts. Better sampling methods that continu-
ously track mosquito movement in space and time, rather than
current methods that sample at known fixed points of interaction,
are therefore needed. Moreover, methods that generate represen-
tative samples of mosquitoes in areas with intensive vector control
activity are needed for accurate monitoring and evaluation of
insecticide resistance and infection rates.
Cross-disciplinary initiatives are also needed to achieve a
defined research agenda for improving engagement and commu-
nication with communities and all other stakeholders in malaria
elimination. Such an agenda is needed to avoid the mistakes of
past efforts, which have all too often foundered because of
community fatigue after long years of engagement. Better inte-
gration of epidemiological expertise into vector control evaluation
initiatives is also needed to ensure accurate field evaluation in
increasingly complex multi-initiative settings, and a more
commercially oriented approach to the development and evalu-
ation of vector control technologies is required to ensure that
promising initiatives cross the translational gap to implementation
and poor technologies are rapidly discarded. Finally, cross-
disciplinary initiatives are needed to achieve the rapid definition
of efficient regulatory pathways and frameworks for existing and
new technologies.
Conclusions
On the basis of its deliberations, the malERA Consultative
Group on Vector Controls proposes a research and development
agenda for vector control (Box 1). The first of these agenda
items—the development of an analytical framework to facilitate
decision making—is achievable in the next 12–18 months. The
other areas need to be rapidly progressed over the next decade. It
will be up to everyone involved in malaria elimination/eradication
to work together to ensure that all the needs and goals highlighted
in this agenda are achieved as efficiently as possible. Importantly,
however, our proposed agenda provides a starting point only for
the research and development needs associated with vector
control. This agenda must not be set in stone; it must continue
to evolve as the elimination/eradication program progresses.
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